Top Markets
Coin of the day
Oncocross Co., Ltd. Oncocross Co., Ltd.

Oncocross Co., Ltd.

382150
Rank in Stocks #27869
Oncocross Co., Ltd. undertakes collaborative research initiatives to discover... Oncocross Co., Ltd. undertakes collaborative research initiatives to discover new drugs, partnering with a variety of pharmaceutical companies both within South Korea and abroad. The company offers a fresh paradigm for drug development by providing analytical insights derived from its advanced artificial intelligence drug discovery platform. Founded by Yi-Rang Kim on June 22, 2015, Oncocross operates from its headquarters located in Seoul, South Korea.
Share Price
$2.50
Market Cap
$30.49M
Change (1 day)
7.11%
Change (1 year)
-59.56%
Country
KR
Trade Oncocross Co., Ltd. (382150)

Category

P/B ratio for Oncocross Co., Ltd. (382150)
P/B ratio as of 2026 TTM: 0
According to Oncocross Co., Ltd. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Oncocross Co., Ltd. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
6.3419 -
US
3.7087 -
US
6.2413 -
NL
2.5054 -
AU
- -
CH